A 20-year incidence trend (1989-2008) and point prevalence (March 20, 2009) of multiple sclerosis in Tehran, Iran: A population-based study

Neuroepidemiology

Volumn 36, Issue 3, 2011, Pages 141-147

  Elhami, Seyedeh Robab ^a   Mohammad, Kazem ^a   Sahraian, Mohammad Ali ^b   Eftekhar, Hassan ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Age adjusted rate; Incidence trend; Iran; Multiple sclerosis, prevalence; Tehran

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; FEMALE; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; POPULATION RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 79954598449     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000324708     Document Type: Article

References (32)

1. Alonso A, Hernán MA: Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-135.
2. Rosati G: The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-139.
3. Pugliatti M, Sotgiu S, Rosati G: The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104:182-191. (Pubitemid 34792722)
4. Kurtzke JF: A reassessment of the distribution of multiple sclerosis. Part 1. Acta Neurol Scand 1975;51:110-136.
5. Kurtzke JF: Epidemiologic contributions to multiple sclerosis: an overview. Neurology 1980;30:61-79.
6. Benamer HTS, Ahmed ESM, Al-Din AS, Grosset DG: Frequency and clinical patterns of multiple sclerosis in Arab countries: a systematic review. J Neurol Sci 2009;278:1-4.
7. Al-Hashel J, Besterman AD, Wolfson C: The prevalence of multiple sclerosis in the Middle East. Neuroepidemiology 2008;31:129-137.
8. Cheng Q, Miao L, Zhang J, Ding SJ, Liu ZG, Wang X, Sun XJ, Zhao ZX, Song YJ, Ding XY, Guo ZL, Yang Y, Chen SD, Jiang GX, Fredrikson S: A population-based survey of multiple sclerosis in Shanghai, China. Neurology 2007;68:1495-1500. (Pubitemid 46685920)
9. Houzen H, Niino M, Hata D, Nakano F, Kikuchi S, Fukazawa T, Sasaki H: Increasing prevalence and incidence of multiple sclerosis in northern Japan. Mult Scler 2008;14:887-892.
10. Papathanasopoulos P, Gourzoulidou E, Messinis L, Georgiou V, Leotsinidis M: Prevalence and incidence of multiple sclerosis in western Greece: a 23-year survey. Neuroepidemiology 2008;30:167-173. (Pubitemid 351667797)
11. Alshubaili AF, Alramzy K, Ayyad YM, Gerish Y: Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence. Eur Neurol 2005;53:125-131. (Pubitemid 40864303)
12. Saadatnia M, Etemadifar M, Maghzi AH: Multiple sclerosis in Isfahan, Iran. Int Rev Neurobiol 2007;79:357-375.
13. Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F: Prevalence of multiple sclerosis in Isfahan, Iran. Neuroepidemiology 2006;27:39-44.
14. Farjadian S, Ota M, Inoko H, Ghaderi A: The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Mol Biol Rep 2009;36:1943-1950.
15. Statistics Center of Iran. http://www.sci.org.ir (accessed September 27, 2009).
16. Palesh M, Fredrikson S, Jamshidi H, Jonsson PM, Tomson G: Diffusion of magnetic resonance imaging in Iran. Int J Technol Assess Health Care 2007;23:278-285. (Pubitemid 46642734)
17. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231. (Pubitemid 13158528)
18. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001;50:121-127.
19. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald criteria'. Ann Neurol 2005;58:840-846.
20. World Health Organization: WHO Statistical Information System (WHOSIS). http://www.who.int/whosis/indicators/compendium/2008/1mst/en/index.html (accessed October 17, 2009).
21. Celius EG, Vandvik B: Multiple sclerosis in Oslo, Norway: prevalence on 1 January 1995 and incidence over a 25-year period. Eur J Neurol 2001;8:463-469.
22. Pugliatti M, Riise T, Sotgiu MA, Sotgiu S, Satta WM, Mannu L, Sanna G, Rosati G: Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology 2005;25:129-134. (Pubitemid 41207065)
23. Hader WJ, Yee IM: Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 2007;69:1224-1229. (Pubitemid 47429022)
24. Turk Boru U, Alp R, Sur H, Gul L: Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey. Neuroepidemiology 2006;27:17-21. (Pubitemid 44114406)
25. El-Salem K, Al-Shimmery E, Horany K, Al-Refai A, Al-Hayk K, Khader Y: Multiple sclerosis in Jordan: a clinical and epidemiological study. J Neurol 2006;253:1210-1216. (Pubitemid 44511480)
26. Gracia F, Castillo LC, Benzadon A, Larreategui M, Villareal F, Triana E, Arango AC, Lee D, Pascale JM, Gomez E, Armien B: Prevalence and incidence of multiple sclerosis in Panama (2000-2005). Neuroepidemiology 2009;32:287-293.
27. Marrie RA: Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol 2004;3:709-718.
28. Dean G, Wadia NH: Multiple sclerosis in the Parsis. J Neurol Neurosurg Psychiatry 1995;58:254.
29. Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG: Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway. J Neurol 2008;255:49-55.
30. Guimond C, Dyment DA, Ramagopalan SV, Giovannoni G, Criscuoli M, Yee IM, Ebers GC, Sadovnick AD: Prevalence of MS in Iranian immigrants to British Columbia, Canada. J Neurol 2010;257:667-668.
31. Ahlgren C, Lycke J, Oden A, Andersen O: High risk of MS in Iranian immigrants in Gothenburg, Sweden. Mult Scler 2010;16:1079-1082.
32. Ebers GC: Environmental factors and multiple sclerosis. Lancet Neurol 2008;7:268-277.